Chinese medicine for COVID-19 A protocol for systematic review and meta-analysis
3800
[키워드] 95% CIs
95% confidence interval
adverse effect
Analysis
appear
article
Asia
asymptomatic infection
cause
CBM
Chest CT
China
Chinese
Chinese medicine
CIs
CNKI
Cochrane Library
Consensus
continuous variable
Controlled trial
Coronavirus disease 2019
COVID-19
database
death
disagreement
disease
East
Efficacy
Efficacy and safety
Evidence
Handbook
hospitalised
include
Infrastructure
journal
literature
mean difference
Meta-analysis
Mild
Novel coronavirus
Nucleic acid detection
Odds ratio
outbreak
outcome
participant
Patient
performed
Placebo
Pneumonia
protocol
recruited
reported
resolved
Respiratory disease
Respiratory failure
Respiratory illness
Respiratory samples
Result
review
risk
risk of bia
Risk of bias
SARS-COV-2 infection
Science
searched
severe viral pneumonia
Spread
systematic review
technique
therapeutic agents
treat
Treatment
upper respiratory tract
variable
VIP
virus
with COVID-19
Wuhan, China
[DOI] 10.1097/MD.0000000000020660 PMC 바로가기 [Article Type] 3800
[DOI] 10.1097/MD.0000000000020660 PMC 바로가기 [Article Type] 3800